First, an adenovirus that delivered expression of mutationally activated Phosphoinositide 3-Kinase (PI3K) appeared to modulate the activity of BRAF in a murine model of lung cancer with a BRAF activating mutation. This evidence concerns the gene BRAF and lung carcinoma.